新型低剖面WEB 17系统治疗颅内动脉瘤的首次临床经验
研究纳入2016年12月至2017年9月40例患者共46个颅内动脉瘤,使用WEB 17治疗,未使用支架或球囊辅助。25个动脉瘤为破裂动脉瘤(54%)。永久性手术并发症率为0%(0/40;97.5%CI,0%-10.4%)。3个月随访39个动脉瘤中28个(72%)完全闭塞,9个(23%)瘤颈残留。作者认为WEB 17对破裂和未破裂动脉瘤均安全有效,尤其适用于非常小的动脉瘤。
要点
- WEB 17经0.017英寸微导管释放,无需支架或球囊辅助即可治疗宽颈动脉瘤。
- 40例患者中永久性手术并发症率为0%(0/40;97.5%CI,0%-10.4%)。
- 3个月随访39个动脉瘤中完全闭塞28个(72%),瘤颈残留9个(23%)。
核心结论
- WEB 17对破裂和未破裂动脉瘤均安全有效,是现有WEB尺寸范围的有价值补充,尤其适用于非常小的动脉瘤。
研究设计与样本
- 首次临床经验研究,2016年12月至2017年9月连续纳入40例患者共46个动脉瘤,均使用WEB 17治疗,未使用支持支架或球囊;其中破裂动脉瘤25个(54%),未破裂动脉瘤21个(46%)。
关键影像表现/征象
- 动脉瘤平均大小4.9 mm(中位数5 mm;范围2-7 mm)。
- 1个动脉瘤因脱离的WEB尺寸过小而额外使用弹簧圈治疗,该动脉瘤3个月时再通并再次以第二个WEB治疗。
- 另1个动脉瘤3个月时显示WEB持续充盈。
诊断标准与关键数值
- 3个月影像随访可评估33例患者共39个动脉瘤(占40个合格动脉瘤的97.5%)。
- 完全闭塞28/39个动脉瘤(72%),瘤颈残留9/39个(23%)。
- 永久性手术并发症率0%(0/40;97.5%CI,0%-10.4%)。
- 术中血栓栓塞并发症2例,无临床后遗症;无术中破裂。
临床应用与阅片要点
- WEB 17适用于破裂和未破裂的宽颈动脉瘤,尤其适用于非常小的动脉瘤(本组动脉瘤大小范围2-7 mm)。
- 3个月随访可见瘤颈残留(9/39,23%)及WEB持续充盈(1个动脉瘤),需在影像随访中关注。
- 1个动脉瘤出现WEB尺寸过小、再通并需二次治疗,提示选择合适尺寸的WEB对疗效的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: The Woven EndoBridge (WEB) is an intrasaccular flow diverter intended to treat wide-neck aneurysms. The latest generation WEBs needed a 0.021-inch microcatheter in the small sizes. Recently, a lower profile range of WEBs compliant with a 0.017-inch microcatheter (WEB 17) has been introduced. We present the first clinical results of treatment of both ruptured and unruptured aneurysms with the WEB 17.
MATERIALS AND METHODS: Between December 2016 and September 2017, forty-six aneurysms in 40 patients were treated with the WEB 17. No supporting stents or balloons were used. Twenty-five aneurysms were ruptured (54%). There were 6 men and 34 women (mean age, 62 years; median, 63 years; range, 46-87 years). The mean aneurysm size was 4.9 mm (median, 5 mm; range, 2-7 mm).
RESULTS: There were 2 thromboembolic procedural complications without clinical sequelae and no ruptures. The overall permanent procedural complication rate was 0% (0 of 40; 97.5% CI, 0%-10.4%). Imaging follow-up at 3 months was available in 33 patients with 39 aneurysms (97.5% of 40 eligible aneurysms). In 1 aneurysm, the detached WEB was undersized and the remnant was additionally treated with coils after 1 week. This same aneurysm reopened at 3 months and was again treated with a second WEB. One other aneurysm showed persistent WEB filling at 3 months. Complete occlusion was achieved in 28 of 39 aneurysms (72%), and 9 aneurysms (23%) showed a neck remnant.
CONCLUSIONS: The WEB 17 is safe and effective for both ruptured and unruptured aneurysms. The WEB 17 is a valuable addition to the existing WEB size range, especially for very small aneurysms.
引用
- van Rooij SBT, Peluso JP, Sluzewski M, et al. The New Low-Profile WEB 17 System for Treatment of Intracranial Aneurysms: First Clinical Experiences. AJNR Am J Neuroradiol. 2018. PMID: 29567650. doi:10.3174/ajnr.A5608
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。